Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy Subjects

Garenoxacin (T-3811ME, BMS-284756) is a novel des-F(6) quinolone that has been shown to be effective in vitro against a wide range of clinically important pathogens, including gram-positive and gram-negative aerobes and anaerobes. This study was conducted to evaluate the safety and tolerability of m...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Gajjar, D. A., Bello, A., Ge, Z., Christopher, L., Grasela, D. M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC161848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12821477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.7.2256-2263.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!